Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 133

1.

High-dose ifosfamide with mesna uroprotection: a phase I study.

Elias AD, Eder JP, Shea T, Begg CB, Frei E 3rd, Antman KH.

J Clin Oncol. 1990 Jan;8(1):170-8.

PMID:
2104923
2.

Ifosfamide and mesna: response and toxicity at standard- and high-dose schedules.

Antman KH, Elias A, Ryan L.

Semin Oncol. 1990 Apr;17(2 Suppl 4):68-73.

PMID:
2110386
3.

A phase I study of high-dose ifosfamide and escalating doses of carboplatin with autologous bone marrow support.

Elias AD, Ayash LJ, Eder JP, Wheeler C, Deary J, Weissman L, Schryber S, Hunt M, Critchlow J, Schnipper L, et al.

J Clin Oncol. 1991 Feb;9(2):320-7.

PMID:
1846407
4.

Ifosfamide with mesna uroprotection and etoposide in recurrent, refractory acute leukemia in childhood. A Pediatric Oncology Group Study.

Bernstein ML, Whitehead VM, Devine S, Grier H, Kung F, Krischer J, Dreyer Z, Bell B, Land V, Buchanan GR, et al.

Cancer. 1993 Sep 1;72(5):1790-4.

PMID:
8348510
5.

Efficacy of ifosfamide in refractory malignant diseases and uroprotection by mesna: results of a clinical phase II-study with 151 patients.

Scheulen ME, Niederle N, Bremer K, Schütte J, Seeber S.

Cancer Treat Rev. 1983 Sep;10 Suppl A:93-101.

PMID:
6414700
6.
7.

Escalating doses of carboplatin with high-dose ifosfamide using autologous bone marrow as support: a phase I study.

Elias AD, Ayash LJ, Eder JP, Wheeler C, Deary J, Weissman L, Hunt M, Critchlow J, Schnipper L, Frei E 3rd, et al.

J Cancer Res Clin Oncol. 1991;117 Suppl 4:S208-13.

PMID:
1795009
8.

High-dose alkylation therapy using ifosfamide infusion with mesna in the treatment of adult advanced soft-tissue sarcoma.

Stuart-Harris RC, Harper PG, Parsons CA, Kaye SB, Mooney CA, Gowing NF, Wiltshaw E.

Cancer Chemother Pharmacol. 1983;11(2):69-72.

PMID:
6414732
9.

Phase II study of continuous-infusion high-dose ifosfamide in advanced and/or metastatic pretreated soft tissue sarcomas.

Palumbo R, Palmeri S, Antimi M, Gatti C, Raffo P, Villani G, Toma S.

Ann Oncol. 1997 Nov;8(11):1159-62.

PMID:
9426338
10.

Response to mesna, doxorubicin, ifosfamide, and dacarbazine in 108 patients with metastatic or unresectable sarcoma and no prior chemotherapy.

Elias A, Ryan L, Sulkes A, Collins J, Aisner J, Antman KH.

J Clin Oncol. 1989 Sep;7(9):1208-16.

PMID:
2504890
11.
12.

High-dose ifosfamide with mesna uroprotection in Ewing's sarcoma.

Jürgens H, Exner U, Kühl J, Ritter J, Treuner J, Weinel P, Winkler K, Göbel U.

Cancer Chemother Pharmacol. 1989;24 Suppl 1:S40-4.

PMID:
2503258
13.

Early phase II Gynecologic Oncology Group experience with ifosfamide/mesna in gynecologic malignancies.

Sutton GP, Blessing JA, Photopulos G, Berman ML, Homesley HD.

Cancer Chemother Pharmacol. 1990;26 Suppl:S55-8.

PMID:
2112054
14.

Phase II experience with ifosfamide/mesna in gynecologic malignancies: preliminary report of Gynecologic Oncology Group studies.

Sutton GP, Blessing JA, Photopulos G, Berman ML, Homesley HD.

Semin Oncol. 1989 Feb;16(1 Suppl 3):68-72.

PMID:
2539647
15.

Dose escalation of the hypoxic cell sensitizer etanidazole combined with ifosfamide, carboplatin, etoposide, and autologous hematopoietic stem cell support.

Elias AD, Wheeler C, Ayash LJ, Schwartz G, Ibrahim J, Mills L, McCauley M, Coleman N, Warren D, Schnipper L, Antman KH, Teicher BA, Frei E 3rd.

Clin Cancer Res. 1998 Jun;4(6):1443-9.

16.

Phase II trial of ifosfamide and mesna in advanced ovarian carcinoma: a Gynecologic Oncology Group Study.

Sutton GP, Blessing JA, Homesley HD, Berman ML, Malfetano J.

J Clin Oncol. 1989 Nov;7(11):1672-6.

PMID:
2509641
17.

A Phase I trial of ifosfamide and paclitaxel with granulocyte-colony stimulating factor in the treatment of patients with refractory solid tumors.

Bunnell CA, Thompson L, Buswell L, Berkowitz R, Muto M, Sheets E, Shulman LN.

Cancer. 1998 Feb 1;82(3):561-6.

PMID:
9452275
18.

A phase I trial of ifosfamide, mesna, and cisplatin in advanced non-small cell lung cancer. A cancer and leukemia group B study.

Graziano SL, Herndon JE 2nd, Richards F 2nd, DiFino S, Modeas C, Duggan DB, Green MR.

Cancer. 1993 Jul 1;72(1):62-8.

PMID:
8389667
19.

High-dose ifosfamide and mesna in advanced breast cancer. A phase II study.

Sanchiz F, Milla A.

Cancer Chemother Pharmacol. 1990;26 Suppl:S91-2.

PMID:
2112057
20.

Phase II study of ifosfamide combined with Mesna uroprotection in advanced non-small-cell lung carcinoma and other solid tumors.

Nobile MT, Rosso R, Brema F, Cinquegrana A, Santi L.

Tumori. 1984 Oct 31;70(5):433-7.

PMID:
6438851

Supplemental Content

Support Center